Cargando…
A 29‐gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival
The molecular complexity displayed in acute myeloid leukemia (AML) hinders patient stratification and treatment decisions. Previous studies support the utility of using specific gene panels for this purpose. Focusing on two salient features of AML, the production of reactive oxygen species (ROS) by...
Autores principales: | Ijurko, Carla, González‐García, Nerea, Galindo‐Villardón, Purificación, Hernández‐Hernández, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303675/ https://www.ncbi.nlm.nih.gov/pubmed/35073432 http://dx.doi.org/10.1002/ajh.26477 |
Ejemplares similares
-
Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison
por: Romo-González, Marta, et al.
Publicado: (2022) -
NOX2: a determinant of acute myeloid leukemia survival
por: Jones, Courtney L.
Publicado: (2022) -
SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia
por: Pérez-Fernández, Alejandro, et al.
Publicado: (2019) -
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias
por: Paolillo, Rosa, et al.
Publicado: (2022) -
Detection of response shift in health-related quality of life studies: a systematic review
por: Ortega-Gómez, Estelina, et al.
Publicado: (2022)